1,782
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer

, , , , , , , , , , , , & show all
Pages 235-247 | Received 22 Feb 2019, Accepted 14 Jun 2019, Published online: 26 Jun 2019

References

  • Mohammed AA, El-Tanni H, El-Khatib HM, et al. Urinary bladder cancer: biomarkers and target therapy, new era for more attention. Oncol Rev. 2016;10:320.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66:7–30.
  • Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374:239–249.
  • Liston P, Roy N, Tamai K, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996;379:349–353.
  • Duckett CS, Li F, Wang Y, et al. Human IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome c. Mol Cell Biol. 1998;18:608–615.
  • Cao Z, Zhang R, Li J, et al. X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis. J Biol Chem. 2013;288:20238–20247.
  • Liu J, Zhang D, Luo W, et al. X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton. J Biol Chem. 2011;286:15630–15640.
  • Mehrotra S, Languino LR, Raskett CM, et al. IAP regulation of metastasis. Cancer Cell. 2010;17:53–64.
  • Jiang G, Wu AD, Huang C, et al. Isorhapontigenin (ISO) inhibits invasive bladder cancer (BC) formation in vivo and human BC invasion in vitro by targeting STAT1/FOXO1 Axis. Cancer Prev Res. 2016.
  • Huang H, Jin H, Zhao H, et al. RhoGDIbeta promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation. Mol Oncol. 2017;11:1579–1594.
  • Yu Y, Jin H, Xu J, et al. XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability. Int J Cancer. 2018;142:2040–2055.
  • Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283:14910–14914.
  • Hur K, Toiyama Y, Takahashi M, et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. 2013;62:1315–1326.
  • Liu L, Qiu M, Tan G, et al. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3. J Transl Med. 2014;12:305.
  • Sun N, Zhang Q, Xu C, et al. Molecular regulation of ovarian cancer cell invasion. Tumour Biol. 2014;35:11359–11366.
  • Wang X, Chen X, Wang R, et al. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.. Oncol Rep. 2013;30:643–650.
  • Ren Y, Han X, Yu K, et al. microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells. Mol Med Rep. 2014;10:315–321.
  • Jin H, Yu Y, Hu Y, et al. Divergent behaviors and underlying mechanisms of cell migration and invasion in non-metastatic T24 and its metastatic derivative T24T bladder cancer cell lines. Oncotarget. 2015;6:522–536.
  • Towler BP, Jones CI, Newbury SF. Mechanisms of regulation of mature miRNAs. Biochem Soc Trans. 2015;43:1208–1214.
  • Gardiner AS, Twiss JL, Perrone-Bizzozero NI. Competing interactions of RNA-binding proteins, microRNAs, and their targets control neuronal development and function. Biomolecules. 2015;5:2903–2918.
  • Chang CJ, Chao CH, Xia W, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol. 2011;13:317–323.
  • Toman R. Basic structural features of a lipopolysaccharide from the Coxiella burnetii strain nine mile in the virulent phase I. Acta Virol. 1992;36:224.
  • Akyurek N, Ren Y, Rassidakis GZ, et al. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas. Cancer. 2006;107:1844–1851.
  • Byrd JC, Kitada S, Flinn IW, et al. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood. 2002;99:1038–1043.
  • Krajewska M, Krajewski S, Banares S, et al. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2003;9:4914–4925.
  • Zhou S, Huang Q, Zheng S, et al. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis. Tumour Biol. 2016;37:6837–6845.
  • Wang C, Ju H, Shen C, et al. miR-429 mediates delta-tocotrienol-induced apoptosis in triple-negative breast cancer cells by targeting XIAP. Int J Clin Exp Med. 2015;8:15648–15656.
  • Nestal de Moraes G, Delbue D, Silva KL, et al. FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance. Cell Signal. 2015;27:2496–2505.
  • Kluger HM, McCarthy MM, Alvero AB, et al. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization. J Transl Med. 2007;5:6.
  • Nagi C, Xiao GQ, Li G, et al. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma. Ann Diagn Pathol. 2007;11:402–406.
  • Nemoto T, Kitagawa M, Hasegawa M, et al. Expression of IAP family proteins in esophageal cancer. Exp Mol Pathol. 2004;76:253–259.
  • Dogan T, Harms GS, Hekman M, et al. X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility. Nat Cell Biol. 2008;10:1447–1455.
  • Kuroda T, Ohyama K. Hypoglossia: case report and discussion. Am J Orthod. 1981;79:86–94.
  • Wang X, Zhao F, He X, et al. Combining TGF-beta1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine. Oncotarget. 2015;6:12493–12504.
  • Sui H, Cai GX, Pan SF, et al. miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer. Mol Cancer Ther. 2014;13:3137–3151.
  • Montminy MR, Bilezikjian LM. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature. 1987;328:175–178.
  • Vitiello L, Ferraro E, De Simone S, et al. CXCL12 prolongs naive CD4+ T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation. Int J Cardiol. 2016;224:206–212.
  • Huang B, Zhu H, Zhou Y, et al. Unconditioned- and conditioned- stimuli induce differential memory reconsolidation and beta-AR-dependent CREB activation. Front Neural Circuits. 2017;11:53.
  • Che X, Liu J, Huang H, et al. p27 suppresses cyclooxygenase-2 expression by inhibiting p38beta and p38delta-mediated CREB phosphorylation upon arsenite exposure. Biochim Biophys Acta. 2013;1833:2083–2091.
  • Zhang R, Wang Y, Li J, et al. The Chinese herb isolate yuanhuacine (YHL-14) induces G2/M arrest in human cancer cells by up-regulating p21 protein expression through an p53 protein-independent cascade. J Biol Chem. 2014;289:6394–6403.
  • Huang H, Zhu J, Li Y, et al. Upregulation of SQSTM1/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cells. Autophagy. 2016;12:1687–1703.
  • Wei J, Du K, Cai Q, et al. Lead induces COX-2 expression in glial cells in a NFAT-dependent, AP-1/NFkappaB-independent manner. Toxicology. 2014;325:67–73.
  • Cao Z, Li X, Li J, et al. X-linked inhibitor of apoptosis protein (XIAP) lacking RING domain localizes to the nuclear and promotes cancer cell anchorage-independent growth by targeting the E2F1/Cyclin E axis. Oncotarget. 2014;5:7126–7137.
  • Du K, Yu Y, Zhang D, et al. NFkappaB1 (p50) suppresses SOD2 expression by inhibiting FoxO3a transactivation in a miR190/PHLPP1/Akt-dependent axis. Mol Biol Cell. 2013;24:3577–3583.
  • Zeng X, Xu Z, Gu J, et al. Induction of miR-137 by Isorhapontigenin (ISO) directly targets Sp1 Protein translation and mediates its anticancer activity both in vitro and in vivo. Mol Cancer Ther. 2016;15:512–522.
  • Xu Z, Zeng X, Xu J, et al. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis. Neuro Oncol. 2016;18(6):830–839.